The treatment of neuroblastoma in children is adjusted according to risk stratification based on multiple features, including age, histological characteristics, stage according to the International Neuroblastoma Staging System (INSS) [2], and molecular profile such as tumor cell DNA ploidy, MYCN, 1p, 17q, and 11q status [3]. Here, MYCN is linked to neuroblastoma.